Cephalosporins - Pharmacological basis of clinical use in veterinary dermatology

Veterinary Dermatology

Volumn 10, Issue 3, 1999, Pages 187-192

  Mason, I S ^a   Kietzmann, M ^b  

^a Veterinary Dermatology Department   (United Kingdom)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Antibiotics; Cephalexin; Cephalosporins; Pharmacodynamics; Pharmacokinetics; Skin; Veterinary dermatology

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; STAPHYLOCOCCUS INTERMEDIUS;

EID: 0033434555     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3164.1999.00183.x     Document Type: Article

References (28)

1. Abraham, E.P. The action of antibiotics on bacteria. In: Florey, H.W. et al. eds. Antibiotics, Vol. II. New York: Oxford University Press, 1949: 1438-96.
2. Flynn, E.H. Cephalosporins and Penicillins: Chemistry and Biology. New York: Academic Press, Inc. 1972.
3. Mandell, G.L., Petri, W.A. Antimicrobial agents. Penicillins, cephalosporins and other β-lactam antibiotics. In: Hardman, J.G. et al. eds. The Pharmacological Basis of Therapeutics. 9th edn. New York: McGraw-Hill, 1996: 1073-101.
4. Tomasz, A. Penicillin binding proteins and the antibacterial effectiveness of β-lactam antibiotics. Reviews in Infections Disease 1986; 8: S270-8.
5. Spratt, B.G. Biochemical and genetic approaches to the mechanism of action of penicillin. Philosophical Transactions of the Royal Society, London (Biology) 1980; 289: 273-83.
6. Waxman, D.J., Yocum, R.R., Strominger, J.L. Penicillins and cephalosporins are active site-directed acetylating agents: evidence in support of the substrate analogue hypothesis. Philosophical Transactions of the Royal Society, London (Biology) 1980; 289: 257-71.
7. Kelley, J.A., Moews, P.C., Know, J.R., Frere, J., Ghuysen, J. Penicillin target enzyme and the antibiotic binding site. Science 1982; 218: 479-81.
8. Barza, M. The nephrotoxicity of cephalosporins: an overview. Journal of Infections Diseases 1978; 137: 560-73.
9. DeSante, K.A., Israel, K.S., Brier, G.L., Wolny, J.D., Hatcher, B.L. Effect of probenecid on the pharmacokinetics of moxalactam. Antimicrobial Agents and Chemotherapy 1982; 21: 58-61.
10. Wackowiez, G., Richard, J.J., Fabreguettes, G. Pharmacokinetics of cephalexin in plasma and urine after single intravenous and oral (tablets) administration in dogs. Journal of Veterinary Pharmacology and Therapeutics 1997; 20(Suppl. 1): 63.
11. Wackowiez, G., Richard, J.J., Fabreguettes, G. Pharmacokinetics of cephalexin in plasma and urine after single intravenous and oral (tablets) administration in cats. Journal of Veterinary Pharmacology and Therapeutics 1997; 20(Suppl. 1): 64-5.
12. Lavy, E., Shem-Tov, M., Or-Bach, A., Ziv, G., Glickman, A., Saran, A. Oral bioavailabiliy and bioequivalence studies in dogs of two cephalexin tablets and a cephalexin capsule.. Journal of Veterinary Pharmacology and Therapeutics 1997; 20(Suppl. 1): 63-1.
13. Kietzmann, M., Mischke, R., Albrecht, N., Nolte, I. Verträglichkeit und Pharmakokinetik von Cefalexin (Cefaseptin) beim Hund. Kleintierpraxis 1990; 35: 390-8.
14. Kietzmann, M., Nolte, I., Strothmann-Luerssen, A., Grünau, B., Schärer, V. Tolerance and pharmacokinetics of cephalexin in cats after oral administration. Journal of Small Animal Practice 1992; 33: 521-5.
15. Otten, H., Plempel, M., Siegenthaler, W. Antibiotika-Fibel. Stuttgart: G. Thieme-Verlag, 1975: 296-301.
16. Bennet, S., Wise, R., Weston, D., Dent, J. Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid. Antimicrobial Agents and Chemotherapy 1983; 23: 831-1.
17. DeBoer, D.J. Strategies for management of recurrent pyoderma in dogs. In: DeBoer, D.J. eds. Veterinary Clinics of North America 1990; 20: 1509-24.
18. Moriello, K.A., Mason, I.S. Handbook of Small Animal Dermatology. Oxford: Pergamon, 1995.
19. Scott, D.W., Miller, W.H., Griffin, C.E. Muller and Kirk's Small Animal Dermatology 5th edn. Philadelphia: W.B. Saunders Co., 1995.
20. Cox, H.U., Hoskins, J.D., Roy, A.F., Newman, S.S., Luther, G.L. Antimicrobial susceptibility of coagulase-positive staphylococci isolated from Louisiana dogs. American Journal of Veterinary Research 1984; 44: 2039-42.
21. Scott, D.W. Feline dermatology 1900-78: a monograph. Journal of the American Animal Hospital Association 1980; 16: 303-459.
22. Medleau, L., Long, R.E., Brown, J., Miller, W.H. Frequency and antimicrobial susceptibility of Staphylococcus species isolated from canine pyodermas. American Journal of Veterinary Research 1986; 47: 229-31.
23. Noble, W.C., Kent, L.E. Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog. Veterinary Dermatology 1992; 3: 71-4.
24. Lloyd, D.H., Lamport, A.I., Feeney, C. Sensitivity to antibiotics amongst cutaneous and mucosal isolates of canine pathogenic staphylococci in the United Kingdom. 1980-96. Veterinary Dermatology 1996; 7: 171-4.
25. Angarano, D.W., MacDonald, J.M. Efficacy of cephadroxil in the treatment of bacterial dermatitis in dogs. Journal of the American Veterinary Medical Association 1979; 194: 57-9.
26. Rosser, E.J. Jr. German shepherd dog pyoderma: a prospective study of 12 dogs. Journal of the American Animal Hospital Association 1997; 33: 355-63.
27. Guaguère, E., Salomon, C., Maynard, L. Utilisation de la céfalexine dans le traitment des pyodermites canines: comparison de l'efficacité de différentes posologies. Practique Médicale et Chirurgicale de l'Animale de Compagnie 1998; 33: 237-46.
28. Frank, L.A., Kunkle, G.A. Comparison of the efficacy of cephadroxil and generic and proprietary cephalexin in the treatment of pyoderma in dogs. Journal of the American Veterinary Medical Association 1993; 203: 530-3.